OBJECTIVE: This study sought to assess the feasibility of performing myocardial perfusion imaging (MPI) with half the technetium activity using ordered-subset expectation maximization with resolution recovery (OSEM-RR), an iterative reconstruction software developed to improve count statistics and acquisition time. METHODS:Two hundred eighteen patients referred for MPI were randomly allocated to undergo stress-rest or rest-stress protocols with standard full-dose (FD) injections of technetium (Tc)-99m sestamibi or half-dose (HD) injections and OSEM-RR processing. Dose activities were adjusted individually by weight. The groups were compared for image quality and clinical results. RESULTS: The groups were similar for mean patient age, weight, and body mass index, sex distribution, pre-test probability of CAD and CAD prevalence. Mean Tc-99m activities for the low-dose and high-dose stages were as follows: FD group: 429 ± 85 MBq and 1132 ± 200 MBq; HD group: 263 ± 129 MBq and 629 ± 85 MBq (P < .0001 for both). Mean effective dose per study was 13.6 ± 1.4 mSv in the FD group and 7.7 ± 1.0 mSv in the HD group (P < .001). Over all image quality was good-to-excellent in 98% and 95% of the groups, respectively. However, when we analyzed the low-dose stage separately, image quality was slightly worse in the HD than the FD, though still within the good-to excellent range. CONCLUSIONS: MPI with nearly half the radiation dose is feasible with good image quality.
RCT Entities:
OBJECTIVE: This study sought to assess the feasibility of performing myocardial perfusion imaging (MPI) with half the technetium activity using ordered-subset expectation maximization with resolution recovery (OSEM-RR), an iterative reconstruction software developed to improve count statistics and acquisition time. METHODS: Two hundred eighteen patients referred for MPI were randomly allocated to undergo stress-rest or rest-stress protocols with standard full-dose (FD) injections of technetium (Tc)-99m sestamibi or half-dose (HD) injections and OSEM-RR processing. Dose activities were adjusted individually by weight. The groups were compared for image quality and clinical results. RESULTS: The groups were similar for mean patient age, weight, and body mass index, sex distribution, pre-test probability of CAD and CAD prevalence. Mean Tc-99m activities for the low-dose and high-dose stages were as follows: FD group: 429 ± 85 MBq and 1132 ± 200 MBq; HD group: 263 ± 129 MBq and 629 ± 85 MBq (P < .0001 for both). Mean effective dose per study was 13.6 ± 1.4 mSv in the FD group and 7.7 ± 1.0 mSv in the HD group (P < .001). Over all image quality was good-to-excellent in 98% and 95% of the groups, respectively. However, when we analyzed the low-dose stage separately, image quality was slightly worse in the HD than the FD, though still within the good-to excellent range. CONCLUSIONS: MPI with nearly half the radiation dose is feasible with good image quality.
Authors: E Gordon DePuey; Srinivas Bommireddipalli; John Clark; Anna Leykekhman; Linda B Thompson; Marvin Friedman Journal: J Nucl Cardiol Date: 2011-02-02 Impact factor: 5.952
Authors: Robert C Hendel; Daniel S Berman; Marcelo F Di Carli; Paul A Heidenreich; Robert E Henkin; Patricia A Pellikka; Gerald M Pohost; Kim A Williams Journal: J Am Coll Cardiol Date: 2009-06-09 Impact factor: 24.094
Authors: Jersey Chen; Andrew J Einstein; Reza Fazel; Harlan M Krumholz; Yongfei Wang; Joseph S Ross; Henry H Ting; Nilay D Shah; Khurram Nasir; Brahmajee K Nallamothu Journal: J Am Coll Cardiol Date: 2010-07-09 Impact factor: 24.094
Authors: W Lane Duvall; Lori B Croft; Tapan Godiwala; Eric Ginsberg; Titus George; Milena J Henzlova Journal: J Nucl Cardiol Date: 2010-11-12 Impact factor: 5.952
Authors: Prashant Kaul; Sofia Medvedev; Samuel F Hohmann; Pamela S Douglas; Eric D Peterson; Manesh R Patel Journal: Circulation Date: 2010-11-08 Impact factor: 29.690
Authors: E Gordon DePuey; Ramesh Gadiraju; John Clark; Linda Thompson; Frank Anstett; Shuli C Shwartz Journal: J Nucl Cardiol Date: 2008-04-24 Impact factor: 5.952
Authors: Reza Fazel; Harlan M Krumholz; Yongfei Wang; Joseph S Ross; Jersey Chen; Henry H Ting; Nilay D Shah; Khurram Nasir; Andrew J Einstein; Brahmajee K Nallamothu Journal: N Engl J Med Date: 2009-08-27 Impact factor: 91.245
Authors: D B Pryor; L Shaw; C B McCants; K L Lee; D B Mark; F E Harrell; L H Muhlbaier; R M Califf Journal: Ann Intern Med Date: 1993-01-15 Impact factor: 25.391
Authors: Albert Juan Ramon; Yongyi Yang; P Hendrik Pretorius; Karen L Johnson; Michael A King; Miles N Wernick Journal: IEEE Trans Med Imaging Date: 2018-12-06 Impact factor: 10.048
Authors: Lotte H Enevoldsen; Changez A K Menashi; Ulrik B Andersen; Lars T Jensen; Otto M Henriksen Journal: J Nucl Cardiol Date: 2013-08-21 Impact factor: 5.952
Authors: Morgan C Lyon; Courtney Foster; Xinhong Ding; Sharmila Dorbala; Don Spence; Manojeet Bhattacharya; A Hans Vija; Marcelo F DiCarli; Stephen C Moore Journal: J Nucl Cardiol Date: 2016-03-31 Impact factor: 5.952